153 related articles for article (PubMed ID: 36759725)
1. Immortal-time bias in older vs younger age groups: a simulation study with application to a population-based cohort of patients with colon cancer.
Pilleron S; Maringe C; Morris EJA; Leyrat C
Br J Cancer; 2023 Apr; 128(8):1521-1528. PubMed ID: 36759725
[TBL] [Abstract][Full Text] [Related]
2. The influence of immortal time bias in observational studies examining associations of antifibrotic therapy with survival in idiopathic pulmonary fibrosis: A simulation study.
Zheng Q; Otahal P; Cox IA; de Graaff B; Campbell JA; Ahmad H; Walters EH; Palmer AJ
Front Med (Lausanne); 2023; 10():1157706. PubMed ID: 37113607
[TBL] [Abstract][Full Text] [Related]
3. Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis.
Weberpals J; Jansen L; van Herk-Sukel MPP; Kuiper JG; Aarts MJ; Vissers PAJ; Brenner H
Eur J Epidemiol; 2017 Nov; 32(11):1019-1031. PubMed ID: 28864947
[TBL] [Abstract][Full Text] [Related]
4. Attention to Immortal Time Bias in Critical Care Research.
Vail EA; Gershengorn HB; Wunsch H; Walkey AJ
Am J Respir Crit Care Med; 2021 May; 203(10):1222-1229. PubMed ID: 33761299
[TBL] [Abstract][Full Text] [Related]
5. Reflection on modern methods: trial emulation in the presence of immortal-time bias. Assessing the benefit of major surgery for elderly lung cancer patients using observational data.
Maringe C; Benitez Majano S; Exarchakou A; Smith M; Rachet B; Belot A; Leyrat C
Int J Epidemiol; 2020 Oct; 49(5):1719-1729. PubMed ID: 32386426
[TBL] [Abstract][Full Text] [Related]
6. Immortal Time Bias in National Cancer Database Studies.
Newman NB; Brett CL; Kluwe CA; Patel CG; Attia A; Osmundson EC; Kachnic LA
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):5-12. PubMed ID: 31404580
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Beta blockers and cancer prognosis - The role of immortal time bias: A systematic review and meta-analysis.
Weberpals J; Jansen L; Carr PR; Hoffmeister M; Brenner H
Cancer Treat Rev; 2016 Jun; 47():1-11. PubMed ID: 27179912
[TBL] [Abstract][Full Text] [Related]
9. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
Colditz GA
Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
[TBL] [Abstract][Full Text] [Related]
10. Estimating the effect of immortal-time bias in urological research: a case example of testosterone-replacement therapy.
Wallis CJD; Saskin R; Narod SA; Law C; Kulkarni GS; Seth A; Nam RK
BJU Int; 2017 Oct; 120(4):584-590. PubMed ID: 28548282
[TBL] [Abstract][Full Text] [Related]
11. Metformin use is not associated with colorectal cancer incidence in type-2 diabetes patients: evidence from methods that avoid immortal time bias.
Zhang HS; Yang Y; Lee S; Park S; Nam CM; Jee SH
Int J Colorectal Dis; 2022 Aug; 37(8):1827-1834. PubMed ID: 35831458
[TBL] [Abstract][Full Text] [Related]
12. Impact of immortal person-time and time scale in comparative effectiveness research for medical devices: a case for implantable cardioverter-defibrillators.
Mi X; Hammill BG; Curtis LH; Greiner MA; Setoguchi S
J Clin Epidemiol; 2013 Aug; 66(8 Suppl):S138-44. PubMed ID: 23849148
[TBL] [Abstract][Full Text] [Related]
13. Use of the landmark method to address immortal person-time bias in comparative effectiveness research: a simulation study.
Mi X; Hammill BG; Curtis LH; Lai EC; Setoguchi S
Stat Med; 2016 Nov; 35(26):4824-4836. PubMed ID: 27350312
[TBL] [Abstract][Full Text] [Related]
14. Distorting Effect of Immortal Time Bias on the Association Between Catheter Ablation for Atrial Fibrillation and Incident Stroke: Caveat Emptor.
Samuel M; Brophy JM; D'Aronco L; Tardif JC; Khairy P
Can J Cardiol; 2021 Mar; 37(3):377-381. PubMed ID: 32979508
[TBL] [Abstract][Full Text] [Related]
15. The Timing, the Treatment, the Question: Comparison of Epidemiologic Approaches to Minimize Immortal Time Bias in Real-World Data Using a Surgical Oncology Example.
Duchesneau ED; Jackson BE; Webster-Clark M; Lund JL; Reeder-Hayes KE; Nápoles AM; Strassle PD
Cancer Epidemiol Biomarkers Prev; 2022 Nov; 31(11):2079-2086. PubMed ID: 35984990
[TBL] [Abstract][Full Text] [Related]
16. Immortal time bias in drug safety cohort studies: spontaneous abortion following nonsteroidal antiinflammatory drug exposure.
Daniel S; Koren G; Lunenfeld E; Levy A
Am J Obstet Gynecol; 2015 Mar; 212(3):307.e1-6. PubMed ID: 25265406
[TBL] [Abstract][Full Text] [Related]
17. Time-dependent biases in observational studies of comparative effectiveness research in rheumatology. A methodological review.
Iudici M; Porcher R; Riveros C; Ravaud P
Ann Rheum Dis; 2019 Apr; 78(4):562-569. PubMed ID: 30755417
[TBL] [Abstract][Full Text] [Related]
18. Practical demonstration of time bias with administration of adjuvant therapy in lung cancer.
Newman NB; Osmundson EC
Lung Cancer; 2021 Jul; 157():75-78. PubMed ID: 33994017
[TBL] [Abstract][Full Text] [Related]
19. Immortal time bias in pharmaco-epidemiology.
Suissa S
Am J Epidemiol; 2008 Feb; 167(4):492-9. PubMed ID: 18056625
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
